OROFACIAL CLEFTS AND MATERNAL ANTICONVULSANT USE

被引：15
|
作者：
SHAW, GM
WASSERMAN, CR
OMALLEY, CD
LAMMER, EJ
FINNELL, RH
机构：
[1] STANFORD UNIV,STANFORD,CA 94305
[2] TEXAS A&M UNIV,COLLEGE STN,TX 77843
来源：
REPRODUCTIVE TOXICOLOGY | 1995年 / 9卷 / 01期
关键词：
D O I：
10.1016/0890-6238(95)93875-J
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
下载
收藏
页码：97 / 98
页数：2
相关论文
共 50 条
  • [21] Maternal occupational physical activity and risk for orofacial clefts
    Agopian, A. J.
    Kim, Jihye
    Langlois, Peter H.
    Lee, Laura
    Whitehead, Lawrence W.
    Symanski, Elaine
    Herdt, Michele L.
    Delclos, George L.
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2017, 60 (07) : 627 - 634
  • [22] The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis
    Xiao, Wen-lin
    Liu, Xiao-ya
    Liu, Yan-shan
    Zhang, Dai-zun
    Xue, Ling-fa
    REPRODUCTIVE TOXICOLOGY, 2017, 69 : 99 - 105
  • [23] Orofacial clefts and spina bifida:: N-acetyltransferase phenotype, maternal smoking, and medication use
    Van Rooij, IALM
    Groenen, PMW
    Van Drongelen, M
    Te Morsche, RHM
    Peters, WHM
    Steegers-Theunissen, RPM
    TERATOLOGY, 2002, 66 (05) : 260 - 266
  • [24] Use of Topiramate in Relation to the Risk of Orofacial Clefts
    Wang, Hao
    Loane, Maria
    Morris, Joan
    Garne, Ester
    Nelen, Vera
    Khoshnood, Babak
    Rissmann, Anke
    Wiesel, Awi
    O'Mahony, Mary
    Pierini, Anna
    Neville, Amanda
    Gatt, Miriam
    de Walle, Hermien
    Addor, Marie-Claude
    Tucker, David
    Klungsoyr, Kari
    Latos-Bielenska, Anna
    Mejnartowicz, Jan
    Verellen-Dumoulin, Christine
    Doray, Berenice
    Arriola, Larraitz
    Barisic, Ingeborg
    Calzolari, Elisa
    Wellesley, Diana
    Dolk, Helen
    de Jong-van den Berg, Lolkje
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 260 - 261
  • [25] Maternal caffeine intake during pregnancy and risk of orofacial clefts
    Collier, S. A.
    Browne, M. L.
    Rasmussen, S. A.
    Honein, M. A.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (05) : 299 - 299
  • [26] Orofacial clefts induced by diabetes are not affected by maternal immune stimulation
    Toops, KA
    Hrubec, TC
    Holladay, SD
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2006, 76 (05) : 333 - 333
  • [27] Orofacial Clefts
    Reiter, R.
    Haase, S.
    Brosch, S.
    LARYNGO-RHINO-OTOLOGIE, 2012, 91 (02) : 84 - 95
  • [28] Use of topiramate in relation to the risk of orofacial clefts.
    Wang, H.
    Loane, M.
    Dolk, H.
    Morris, J.
    Garne, E.
    De Jong-van den Berg, L. T. W.
    Verellen-Dumoulin, C.
    Nelen, V
    Barisic, I
    Khoshnood, B.
    Doray, B.
    Rissmann, A.
    Wiesel, A.
    O'Mahony, M.
    Pierini, A.
    Neville, A.
    Gatt, M.
    Bakker, M.
    Klungsoyr, K.
    Latos-Bielenska, A.
    Mejnartowicz, J.
    Arriola, L.
    Addor, M-C
    Tucker, D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 11 - 12
  • [29] Corticosteroid use during pregnancy and risk of orofacial clefts
    Hviid, Anders
    Molgaard-Nielsen, Ditte
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (07) : 796 - 804
  • [30] A Case-Control Study of Maternal Occupation and the Risk of Orofacial Clefts
    Kim, Jihye
    Langlois, Peter H.
    Herdt-Losavio, Michele L.
    Agopian, A. J.
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2016, 58 (08) : 833 - 839
12345